Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Indications & Uses
Lipodes-L tablet is indicated in conjunction with diet and exercise for the treatment of adults with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis).
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
The recommended dose of Resmetirom is based on actual body weight. For patients weighing: <100 kg, the recommended dose is 80 mg orally once daily. >100 kg, the recommended dose is 100 mg orally once daily. Resmetirom can be administered with or without food.
Side Effects
The common side effects of Lipodes-L are: Diarrhea, Nausea, Vomiting, Abdominal pain, Dizziness, Pruritus, Constipation.
Cautions & Contraindications
Warnings & Precautions
Hepatotoxicity: Hepatotoxicity has been observed with use of Lipodes-L. Monitoring of patient is required during treatment with Lipodes-L for elevations in liver tests, for the development of liver-related adverse reactions and for sign & symptoms of hepatotoxicity. If hepatotoxicity is suspected, Lipodes-L should be discontinued and monitoring of the patient should be continued. If laboratory values return to baseline, the potential risks against the benefits of restarting Lipodes-L should be considered. If laboratory values do not return to baseline, DI-ALH or autoimmune liver disease should be considered in the evaluation of elevations in liver tests.Gallbladder-Related Adverse Reactions: In clinical trials, cholelithiasis, acute cholecystitis, and obstructive pancreatitis (gallstone) were observed in Lipodes-L-treated patients. If cholelithiasis is suspected, gallbladder diagnostic studies and appropriate clinical follow-up are indicated , If an acute gallbladder event is suspected, Lipodes-L treatmentshould be interrupted until the event is resolved.Drug Interaction with Certain Statins: An increase in exposure of Atorvastatin, Pravastatin, Rosuvastatin and Simvastatin was observed when concomitantly administered with Lipodes-L, which may increase the risk of adverse reactions related to these drugs. Dosage adjustment for certain statins is recommended.